Press Release

CardioDx Selects EtQ Reliance Compliance Management Solution for Medical Device

FARMINGDALE, NY (07-09-08): EtQ has announced the implementation of EtQ Reliance for Medical Device Software at CardioDx. CardioDx is developing a series of molecular tests for diagnosing cardiovascular disease that will enable physicians to make better-informed treatment decisions.

It was CardioDx's decision to move away from a decentralized Quality system and implement a software platform that would allow them to manage an enterprise Quality Management System (QMS), with the ability to integrate with their existing business systems and automate business processes.

EtQ has been able to provide a solution that is flexible enough to grow with CardioDx as they expand their operations, and grow their business. Using EtQ's robust set of modules such as Document Control, Training, and Corrective Action/Preventive Action, CardioDx will be able to automate their quality process, integrate quality to their operation, and collaborate across the enterprise while providing a level of flexibility to configure the software to meet their specific business needs.

"For CardioDx, EtQ is flexible enough to adapt and scale to their growing business, while maintaining the high level of compliance needed to meet the demand of the FDA," states Glenn McCarty, Chief Executive Officer at EtQ. EtQ is able to provide a solution that is flexible enough to match business process exactly, while maintaining compliance to FDA requirements, with enhanced security features, electronic signatures, audit trail tracking, and maintaining compliance to FDA initiatives.

About CardioDx

Founded in 2004, CardioDx is a molecular diagnostics company located in Palo Alto, CA. CardioDx is developing clinically validated molecular diagnostics specifically for cardiovascular disease. Through novel molecular tools and informatics, the company's products and services empower physicians with more precise information and greater confidence for individual treatment decisions. CardioDx diagnostic tests will help cardiologists identify patients who will benefit most from advanced cardiovascular therapies, enabling them to deliver the right treatment to the right patient at the right time.

About EtQ

EtQ is the leading Quality, EHS, Operational Risk and Compliance management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. At the core of EtQ’s framework is a compliance management platform that enables organizations to implement best-in-class compliance processes configured to meet their existing processes, create new compliance processes and automate and control their compliance ecosystem. EtQ’s product lineup includes Reliance™ for enterprise organizations and Verse Solutions™ for mid-sized businesses. EtQ was founded in 1992 and has main offices located in the U.S. and Europe. To learn more about EtQ and its various product offerings, visit www.etq.com or blog.etq.com.

For more information about EtQ, please visit www.etq.com, or to schedule a virtual demo, contact EtQ Inc., at 800-354-4476 or 516-293-0949, or e-mail us at info@etq.com.

EtQ is a trademark of EtQ Management Consultants, Inc. All other product names and company names are trademarks or registered trademarks of their respective owners.

Press Contact:

Brenda Percy
bpercy@etq.com